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Lineage commitment is induced by changes in
gene expression dictated by the intimate inter-
action between transcription factors and chro-
matin regulators. Here, we revealed the antago-
nistic interplay between Ikaros and its associate
the chromatin remodeler Mi-2b during T cell de-
velopment, as exemplified by the regulation of
Cd4 expression. Loss of Ikaros or Mi-2b led to
activation or repression, respectively, of the
Cd4 locus at inappropriate stages of develop-
ment. Their combined mutation reverted to
normal CD4 expression. In double-negative thy-
mocytes, Ikaros binding to theCd4 silencer con-
tributed to its repressive activity. In double-
positive thymocytes, concomitant binding of
Mi-2bwith Ikaros to the Cd4 silencer caused si-
lencer inactivation, thereby allowing for CD4 ex-
pression. Mi-2b facilitated recruitment of his-
tone acetyl transferases to the silencer. This
recruitment possibly antagonized Ikaros and
associated repressive activities. Thus, concom-
itant interactions between functionally oppos-
ing chromatin-regulating machineries are an im-
portant mode of gene regulation during lineage
determination.
INTRODUCTION
Cellular identity is determined by gene-expression pat-
terns that are established early in development. The tran-
scriptional regulation of lineage-specific genes has been
studied extensively as a means to delineate the molecular
events underlying the differentiation process. There has
been an increasing recognition that changes in chromatin
structure over developmentally regulated gene loci play
a key role in enabling developmental decisions (Ng et al.,
2007). In undifferentiated embryonic stem cells, many
lineage-determining genes aremarked by a ‘‘bivalent’’ his-
tone code, in which nucleosomes are marked by both ‘‘re-Impressive’’ and ‘‘activating’’ histone modifications (Bern-
stein et al., 2006). These modifications appear to resolve
into either repressive-only or activating-only modifications
upon differentiation. Thus, a bivalent code appears to be
important for marking and possibly maintaining lineage-
specific genes in a poised state whose expression is fur-
ther modulated during differentiation. This type of mecha-
nism might be utilized in many developmental processes
including lymphopoiesis (Kioussis and Georgopoulos,
2007). An important question that is raised in these studies
is how the initial bipotent chromatin is generated and then
resolved into a monopotent structure during lineage com-
mitment. Chromatin-structure regulators that include his-
tone-modifying enzymes and ATP-dependent chromatin
remodelers are likely to play crucial roles in these pro-
cesses leading along a differentiation pathway (Georgo-
poulos, 2002). Thus, investigating their mode of operation
at themolecular level is critical for our understanding of the
lineage-commitment process.
In the T cell differentiation pathway, several discrete de-
velopmental stages and the acquisition or loss of the
helper and cytotoxic cell fates are demarcated by the
sequential acquisition or loss of expression of the CD4
and CD8 coreceptors. Immature cells in the thymus ex-
press neither CD4 nor CD8 and are defined as double neg-
ative (DN) for coreceptor expression. At the DN stage,
cells begin to rearrange the T cell receptor (TCR) b-chain
locus, and only those that have undergone productive
rearrangements progress to the double positive (DP)
stage where they express both CD8 and CD4. Rearrange-
ment of the TCR a-chain locus takes place in DP thymo-
cytes and is followed by selection of those with appropri-
ate TCRs into the CD4+ or CD8+ single positive (SP)
effector state. Because the stage-specific activation of
these coreceptors underlies many important develop-
mental and effector function decisions in the T cell path-
way, the transcriptional regulation of the Cd4 and Cd8
genes remains of great interest. Although the Cd4 and
Cd8 genes share some common transcription regulatory
factors, these appear to have disparate effects on expres-
sion of the coreceptors (Chi et al., 2002; Sato et al., 2005;
Taniuchi and Littman, 2004).
Studies on the transcriptional regulation of the Cd4
locus have identified two distinct enhancer regions thatmunity 27, 723–734, November 2007 ª2007 Elsevier Inc. 723
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Mi-2b Antagonizes Ikaros on Cd4 Silencer Activityare active in T cells (Adlam and Siu, 2003; Sawada and
Littman, 1991).However, transgenic experiments revealed
that the Cd4 enhancers do not confer stage-specific
expression (Manjunath et al., 1999; Sawada et al., 1994;
Siu et al., 1994; Williams et al., 2004). The key element
responsible for lineage-specific expression of Cd4 is a
silencer that is located within the first intron of the
Cd4 gene (Sawada et al., 1994; Siu et al., 1994). The Cd4
silencer represses expression of the Cd4 locus through
what appears to be functionally distinct mechanisms at
the DN and CD8+ SP stages of T cell development (Taniu-
chi and Littman, 2004). At the DN stage, this silencer ac-
tively represses Cd4 expression. This repression is read-
ily reversed upon the DN-to-DP transition. At the CD8+ SP
stage, the silencer is involved in the silencing of the Cd4
locus and prohibits the locus’s re-expression in mature
cells of the CD8+ T cell lineage. Several trans-acting fac-
tors have been implicated in silencer function. These in-
clude the SWI-SNF chromatin-remodeling complex (Chi
et al., 2002) and the Runx family of sequence-specific
DNA-binding proteins (Taniuchi et al., 2002a). Runx inter-
actions with the heterochromatin protein HP1 and with
a transcription elongation factor have been implicated in
this process; nonetheless, the molecular mechanism by
which these proteins mediate silencer function remains
unclear (Jiang et al., 2005; Taniuchi et al., 2002b; Zou
et al., 2001).
Ikaros is an important regulator of lymphocyte develop-
ment and T cell homeostasis and has been implicated in
both activation and repression of gene expression during
development (Georgopoulos, 2002; Thompson et al.,
2007; Trinh et al., 2001). In differentiating T cells, Ikaros
proteins associate with the nucleosome remodeling and
histone deacetylase (NuRD) complex, which possess
both chromatin-remodeling and histone-modification ca-
pabilities (Kim et al., 1999; O’Neill et al., 2000). The ATP-
dependent chromatin remodeler Mi-2b, a core component
of theNuRDcomplex that binds directly to Ikaros, has been
implicated in the negative regulation of gene expression in
part because of its association with histone deacetylases
(Tong et al., 1998;Wadeet al., 1998; Xue et al., 1998; Zhang
et al., 1998). Mi-2b can also exert a positive role in gene
expression, possibly through its association with other
chromatin regulators such as histone acetyltransferases
(HATs) or histone methylases (Nakamura et al., 2002;
Shimono et al., 2003; Williams et al., 2004). Given the phys-
ical association of Ikaros and Mi-2b and their key roles
in normal T cell differentiation, it is crucial to investigate
their synergistic effects on gene expression during devel-
opment.
Here, we demonstrated that during T cell differentiation,
the Cd4 locus is regulated by an antagonistic interaction
between Mi-2b and Ikaros. We revealed a role for Ikaros
in the repression of the Cd4 locus at the DN stage and
a role for Mi-2b in countering the Ikaros repression during
the DN-to-DP transition. Our results shed new light on how
the Cd4 silencer activity is modulated during T cell devel-
opment through these two key nuclear regulatory factors
and associated chromatin modifiers.724 Immunity 27, 723–734, November 2007 ª2007 Elsevier IncRESULTS
Genetic Interactions between Ikaros and Mi-2b
Reciprocally Affect CD4 Regulation
The majority of Ikaros protein expressed in thymocytes
exists in a complex with the chromatin remodeler Mi-2b
(Kim et al., 1999; Sridharan and Smale, 2007). To elucidate
the functional consequence of this interaction during T cell
development, we combined the Ikaros and Mi-2b muta-
tions and analyzed double as well as single mutants for
their thymocyte profiles.
As previously shown, Mi-2b single mutants displayed
a prominent increase in CD8+ SP thymocytes, the majority
of which were DP that failed to express the CD4 corecep-
tor (Figure 1A, DMi-2b TCRmedCD5med) (Williams et al.,
2004). In contrast, Ikaros null mutants showed an increase
in CD4+ SP thymocytes. These cells contained an in-
creased CD4+ SP population (Figure 1A, DIkaros
TCRhiCD5hi), and DP cells that failed to express the CD8
coreceptor contained an increased population as well
(Figure 1A, DIkaros TCRmedCD5med) (Harker et al., 2002;
Urban and Winandy, 2004). Unexpectedly, in the Ikaros
and Mi-2b double mutants, the thymocyte profile reverted
to that of the Ikaros single mutants (Figure 1A, DMi-2b-DI-
karos). Analysis of these cells for Mi-2b deletion indicated
that their great majority had deleted Mi-2b. The 10%
increase in Mi-2b-undeleted cells detected in the double
mutant relative to the single Mi-2b mutant could not ac-
count for the observed complete conversion from an Mi-
2b- to an Ikaros-like phenotype (Figure 1A and Figure S1
in the Supplemental Data available online). Thus, the
loss of CD4 expression in DP caused by lack of Mi-2b
was corrected upon concomitant depletion of Ikaros.
This suggests that in the absence of Mi-2b, Ikaros is re-
sponsible for the inappropriate repression of the Cd4
locus in DP thymocytes.
In search of further evidence for Ikaros’ involvement in
the repression of the Cd4 locus, we examined Ikaros-
deficient DN and CD8+ SP thymocytes. The DN compart-
ment can be further subdivided into DN1-DN4 populations
by the CD44 and CD25 markers. Because the DN1 and
DN2 subsets were drastically reduced in the Ikarosmutant
thymus (Winandy et al., 1999), we restricted our analysis
to the DN3 and DN4 and a transitional population between
them. An increase in CD4 expression was detected in the
Ikaros mutant DN3 population compared to wild-type
(Figure 1D, bottom left). Derepression of CD4 became
more prominent as mutant thymocytes progressed from
the DN3 to the DN4 stage, indicating that Ikaros activity
is required for repression of Cd4 and prevention of its
premature upregulation at these early stages of T cell dif-
ferentiation (Figure 1D, bottom middle to right). Cd4 si-
lencing in CD8+ SP thymocytes was unaffected by the
loss of Ikaros because no increase in DP thymocytes ex-
pressing high amount of TCRb was observed (Figure 1A).
Taken together, these genetic studies on Ikaros andMi-
2b reveal their antagonistic interactions in the regulation of
the Cd4 locus during T cell development. These provide
support for a model by which at the DN stage Ikaros.
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Mi-2b Antagonizes Ikaros on Cd4 Silencer ActivityFigure 1. Genetic Interactions between Mi-2b and Ikaros Determine Activity of the Cd4 Locus during T Cell Development
(A) Loss of Ikaros corrects the CD4 expression deficiency manifested upon loss of Mi-2b in DP thymocytes. In the top row, whole thymocyte CD4 and
CD8 profiles of wild-type (WT), DIkaros, DMi-2b, and DIkaros-DMi-2b are shown. In the bottom three rows, SP, DP, and DN thymocytes are gated
according to their TCRb and CD5 expression and then analyzed for expression of CD4 and CD8.
(B) PCR genotyping of thymocytes from single and combined mutants for Ikaros and Mi-2b. WT and mutant bands resulting from excision of respec-
tive Ikaros and Mi-2b genetic loci are indicated.
(C) Thymic cellularity of mutants. The average and standard deviation (SD) from more than seven mice (two- to four-weeks old) of each genotype are
shown.
(D) Premature upregulation of CD4 in Ikaros null DN thymocytes. DN cells were identified as lineage marker (CD8, TCRb, TCRgd, B220, Ter119, Mac-
1, and Gr-1) -negative thymocytes. The CD44 and CD25 profiles of DN cells fromWT andDIkaros are shown at the top. Overlays of CD4 expression in
WT (gray shadow) and DIkaros (black) subpopulations are shown at the bottom. Representative data of six independent experiments are shown.represses CD4 expression, whereas at the next stage of
differentiation—the DP stage—repression by Ikaros is re-
lieved by Mi-2b, enabling CD4 expression. In the absence
of Mi-2b, Ikaros remains active in CD4 repression in DP
thymocytes, thereby causing the aberrant CD4 expres-
sion profile detected in Mi-2b-deficient thymocytes.
A Direct Association of Ikaros and Mi-2b
with the Cd4 Silencer
Previous studies have shown that a silencer element
located in the first intron of Cd4 locus (Figure 2A) dictates
stage-specific expression of Cd4 gene. Given the genetic
evidence that Ikaros functions as a repressor of CD4,
whereas Mi-2b enables CD4 expression by countering
Ikaros function, we examined whether the effects of these
factors were directed through the Cd4 silencer by using
chromatin immunoprecipitation (ChIP) approaches. The
interaction between these factors and a downstream
region (exon 10) of the Cd4 locus that contains no regula-
tory elements was also tested as a control.
An association of both Ikaros and Mi-2b with the Cd4
silencer was apparent in total thymocytes, which in their
majority (>80%) consist of DP cells (Figures 2B and 2C).
Association between these factors and the downstreamImcontrol genomic region was negligible (Figures 2B and
2C). The Ikaros binding to the Cd4 silencer was reduced
to a background level in Ikaros-deficient thymocytes,
thus confirming the specificity of this interaction. How-
ever, the Ikaros association with the Cd4 silencer was
preserved in Mi-2b deficient thymocytes, indicating that
activity of this chromatin remodeler was not required for
Ikaros’ recruitment to this chromosomal site (Figure 2B).
In a similar fashion, Mi-2b enrichment over the Cd4 si-
lencer was greatly diminished in Mi-2b deficient thymo-
cytes, confirming the specificity of theMi-2bChIP. A small
but significant reduction in Mi-2b association with theCd4
silencer was detected in the absence of Ikaros, suggest-
ing that the Mi-2b ability to be targeted to this regulatory
region is partly dependent on Ikaros (Figure 2C). Because
CD4 repression by Ikaros takes place in DN cells, we also
examined the binding of these factors in DN cells. Ikaros
binding was detected at the silencer, but only minimal
Mi-2b enrichment was seen at this stage of development
(Figure 2D).
Ikaros direct binding to the Cd4 silencer supports the
idea that its negative effects on Cd4 expression are
exerted through this negative regulatory region. The direct
association of Mi-2bwith the silencer in DP cells suggestsmunity 27, 723–734, November 2007 ª2007 Elsevier Inc. 725
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Mi-2b Antagonizes Ikaros on Cd4 Silencer ActivityFigure 2. Mi-2b and Ikaros Directly Associate with the Cd4 Silencer
(A) Genomic organization of Cd4 locus. Locations of exons (black bars) and regulatory elements (light-gray bars: Prox Enh, proximal enhancer; Prom,
promoter; and Sil, silencer) are depicted.
(B) Ikaros binding to the silencer inWT andDIkaros or inWT andDMi-2b thymocytes.We performed ChIPwithWT andDIkaros or withWT andDMi-2b
samples by using a-Ikaros antibodies. Precipitated DNA was analyzed by multiplex PCR (upper panels). The white arrowhead indicates the internal
control band. Fold-enrichment was calculated as ([Signaltarget/Signalinternal control] for a-Mi-2b [or for a–Ikaros] ChIP)/([Signaltarget/Signalinternal control] for
the input), and the average and SD from more than five independent experiments are shown at the bottom panel. A p value < 0.05 by a paired
Student’s t test is marked by asterisks.
(C)Mi-2b binding to the silencer inWT andDIkaros or inWT andDMi-2b thymocytes. ChIPwas performedwithWT andDMi-2b or withWT andDIkaros
thymocytes. The results are calculated as in (B) and are representative of more than five independent experiments.
(D) Ikaros and Mi-2b binding in DN cells. a-Ikaros or a-Mi-2b ChIP was performed with Rag1/ thymocytes. The average and SD from two (Ikaros)
and three (Mi-2b) independent experiments are shown. Asterisk indicates p < 0.05 by a paired Student’s t test.726 Immunity 27, 723–734, November 2007 ª2007 Elsevier Inc.
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Mi-2b Antagonizes Ikaros on Cd4 Silencer ActivityFigure 3. Mi-2b Inactivates the Cd4 Silencer in DP Thymocytes
(A) Expression of aCd4 silencer-based reporter expression inWT andMi-2b-deficient thymocytes. The structure of the reporter is shown at the top of
the panel (E,Cd3d enhancer; P,Cd3d promoter; S,Cd4 silencer; and pA, SV40 polyA signal). Overlays of reporter expression inWT (gray) andmutant
(black) DN and DP for TG11-505 line are provided (bottom panels). Staining of a nontransgenic control is shown in gray shadow.
(B) Expression of the control reporter in DP thymocytes. The structure of the reporter is shown at the top. The overlay of WT and mutant expression
profiles of the DS73 line in the DN and DP populations (as in [A]) are shown at the bottom.
(C) Strategy for identifying thymocyte subsets. WT and DMi-2b thymocytes were delineated according to their CD8 and TCRb expression. The gates
that are used to reveal the CD4+ SP, CD8+ SP, DP, and DN subsets in WT and Mi-2b mutant are shown.
(D) Expression of the silencer-based reporter decreases in Mi-2b-deficient DP thymocytes. The percentage of hCD2-expressing cells in three
independent silencer transgenic reporter lines is shown. Black bars indicate the mean expression. A hCD2-positive gate was set to exclude
99.5% of the nonreporter thymocytes. Statistical significance of the difference between WT and Mi-2b mutant was examined by an unpaired
Student’s t test, and p < 0.05 is indicated by asterisks.
(E) Mi-2b deletion does not affect the expression of a control reporter lacking the Cd4 silencer. Analysis of the data from three independent lines was
performed as in (D).that this remodeler might enable CD4 expression by coun-
teracting the Cd4 silencer activity conferred by Ikaros at
this stage in development.
Mi-2b Negatively Regulates the Activity
of the Cd4 Silencer
Mi-2b also binds to and positively regulates the Cd4 en-
hancer (Williams et al., 2004); thus, any effect of Mi-2b
on Cd4 silencer activity is difficult to discern in the context
of the endogenous Cd4 locus. To overcome this problem,
we tested the role of Mi-2b on Cd4 silencer function in the
context of a heterologous Cd3d enhancer-promoter (E-P)
combination (Figure 3A, top). A second transgenicImreporter that lacks the Cd4 silencer was used as a control
(Figure 3B, top). Three transgenic lines for each of the
silencer and control reporters were generated, and their
expression was examined in both wild-type and Mi-2b-
depleted thymocyte subsets.
Because Mi-2b depletion causes the downregulation of
the Cd4 locus, identification of DP subsets in wild-type
and mutant thymocytes was based on TCRb and CD8 ex-
pression, which remains largely unaffected by the Mi-2b
mutation (Figure 3C). Expression of the silencer-based
reporter was not detected in DN (TCRblo CD8–) thymo-
cytes in any of the three transgenic lines on either of the
wild-type or Mi-2b mutant background (Figure 3A, DN,munity 27, 723–734, November 2007 ª2007 Elsevier Inc. 727
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Mi-2b Antagonizes Ikaros on Cd4 Silencer Activitygray and black histograms). As expected, expression of
the silencer-based reporter was induced in wild-type DP
thymocytes because of normal inactivation of the silencer
(Figure 3A, ‘‘DP,’’ gray histogram). In contrast, Mi-2b defi-
cient DP thymocytes failed to induce this reporter to the
amount detected in their wild-type counterparts, indicat-
ing that the silencer remained inappropriately active in
the absence of the remodeler (Figure 3A, ‘‘DP,’’ black his-
togram). Extensive analyses of the three independently
established transgenic lines revealed that expression of
the silencer-containing reporter was significantly de-
creased in Mi-2b mutant DP thymocytes (Figure 3D). In
contrast to the silencer-containing reporter lines, no
significant difference in expression between wild-type
and mutant DP thymocytes was observed with the
transgenic lines generated with a control reporter lack-
ing the silencer (Figure 3E). Because the only differ-
ence between the two transgenic reporters is the pres-
ence or absence of the silencer, the difference in
expression of the silencer-containing reporter in mutant
DP is probably due to an effect on the silencer rather
than on the Cd3d E-P elements, which are shared by
both reporters. This conclusion was further supported
by the observation that expression of the endogenous
Cd3d was not discernibly affected by the Mi-2b muta-
tion (Figure S2).
Thus, the activity of the Cd4 silencer in CD4 expressing
thymocytes is under negative regulation by the chromatin
remodeler Mi-2b. Mi-2b’s potential mode of action in
silencer inactivation is to antagonize an Ikaros-repressive
activity.
Mi-2b and Ikaros in the Recruitment of Other
Chromatin Regulators to the Cd4 Silencer
To further elucidate the molecular mechanism by which
Mi-2b and Ikaros regulate silencer function, we tested
the involvement of additional chromatin regulators that
partner with these factors. For example, histone deacety-
lases (HDACs) associate with both Mi-2b and Ikaros
through the NuRD complex and with Ikaros through
a Sin3 complex in lymphocytes (Kim et al., 1999; Koipally
et al., 1999). Interestingly, HDAC2 exhibited an associa-
tion with the Cd4 silencer when examined in total thymo-
cytes, the majority of which expressed CD4 (Figure 4A).
Thus, the presence of HDAC2 on the Cd4 silencer does
not correlate with silencer activity or with the state of acti-
vation of the Cd4 locus. HDAC occupancy of the Cd4 si-
lencer remained unaffected upon loss of Mi-2b or Ikaros
(Figures 4A and 4B), indicating that changes in HDAC re-
cruitment are not responsible for the respective CD4 ex-
pression phenotypes. In addition to theMi-2b-NuRD com-
plex, HDAC also associates with the Sin3 complex (Alland
et al., 1997; Heinzel et al., 1997; Laherty et al., 1997).
The association of Sin3A with the Cd4 silencer was tested
in the presence or absence of Ikaros andMi-2b. Sin3Awas
present on the Cd4 silencer in CD4-expressing thymo-
cytes. As predicted, lack of Mi-2b did not influence
Sin3A association with the silencer (Figure 4C). A small
but significant reduction in Sin3A recruitment to the Cd4728 Immunity 27, 723–734, November 2007 ª2007 Elsevier Incsilencer was detected in the absence of Ikaros (Figure 4D).
A potential effect on the recruitment of Runx1, an indepen-
dent key silencing factor of the Cd4 locus, was also tested
in the absence of Mi-2b and was found unchanged
(Figure 4E). Thus, the increase in silencer activity caused
by the loss of Mi-2b does not involve an increase in the
recruitment of negative regulatory factors (HDAC, Sin3,
Runx1, and Ikaros), which appear to be stably associated
with the Cd4 silencer in thymocytes regardless of its
activity and the state of CD4 expression.
An alternative means for changing Cd4 silencer activity
is by altering the recruitment of positive regulators to this
region. We have previously shown that the HATs, p300
and CBP, are recruited to the proximal enhancer region
in an Mi-2b-dependent fashion. However these factors
were not enriched over the silencer (data not shown). In-
stead, we found that MOZ, a MYST type of HAT originally
identified as a fusion partner of CBP in acutemyelogenous
leukemia (Borrowet al., 1996),washighly enrichedwith the
silencer compared to the otherCd4 regulatory elements in
an Mi-2b-dependent fashion (Figure 4F and Figure S3). In
addition, TAFII250, the largest subunit of the basal tran-
scription factor complex TFIID that possessesHAT activity
(Mizzen et al., 1996), was enriched at the silencer, the
enhancer, and a region immediately downstream of the
transcription initiation site but not at a further downstream
genomic region (Figure 4G and Figure S3). TAFII250 inter-
actions with these regulatory regions were Mi-2b depen-
dent and were reduced upon Mi-2b depletion. Associa-
tions of other HATs such as Gcn5, PCAF, and Tip60 with
the Cd4 silencer were also tested but no substantial en-
richment was observed (data not shown).
These studies reveal an Mi-2b-dependent HAT recruit-
ment to the Cd4 silencer. Antagonistic interactions be-
tween Mi-2b-recruited HATs and the resident HDACs at
the Cd4 silencer are likely to dictate the transcriptional
activity of the Cd4 locus during T cell development.
Dynamic Changes in Histone Acetylation at the
Cd4 Silencer during T Cell Development
Given the occupancy of the Cd4 silencer by HDACs and
HATs, we examined its underlying chromatin structure rel-
ative to that of other Cd4 regulatory regions during T cell
development.
In unfractionated wild-type thymocytes, of which the
great majority express CD4 (95%), the silencer is greatly
enriched for acetylated histone H3 (AcH3). Interestingly,
the amount of AcH3 over the silencer is much greater
than that seen over the enhancer and its proximal region
(Figure 5A). In addition to the silencer and the enhancer,
exon 1 was also highly acetylated, probably as a con-
sequence of active transcription. Other regions of the
Cd4 gene did not display a similar great amount of
AcH3. Acetylated histone H4 (AcH4) was also enriched
in the vicinity of the enhancer and silencer regions, al-
though in this case acetylation was greater over the en-
hancer compared to the silencer. Upon Mi-2b depletion,
acetylation of H3 and H4 over the silencer was greatly re-
duced (Figure 5A, gray lines). The decrease in histone.
Immunity
Mi-2b Antagonizes Ikaros on Cd4 Silencer ActivityFigure 4. Cofactor Recruitment to the Cd4 Silencer and Effects by Ikaros or Mi-2b Mutation
(A, C, and E–G) Mi-2bmutation affects the recruitment of HATs but not of HDAC or of other negative regulators. The association of HDAC2 (A), Sin3A
(C), Runx1 (E), MOZ (F), and TAFII250 (G) with the silencer or with exon 10 was examined in the WT and Mi-2b mutant. Left panels show the repre-
sentative duplex PCR results. White arrowheads indicate the internal controls, whereas black arrowheads indicate the target bands. Bar graphs on
right panels showmean and SD of fold enrichment frommore than three independent experiments. Statistical significance of the difference between
theWT andmutant was examined by a paired Student’s t test. A single asterisk indicates a p value < 0.05. Double asterisks indicate that the p value for
(mutant enrichment)/(wild-type enrichment) is < 0.05.
(B and D) Effects of Ikaros mutation on the recruitment of Sin3A and HDAC. The association of HDAC2 (B) and Sin3A (D) with the Cd4 silencer or with
exon 10 was examined inWT and Ikaros mutant thymocytes as in (A). Mean and SD of fold enrichment frommore than four independent experiments
is shown on the right panel.acetylation observed in Mi-2b mutant thymocytes could
be due to a change in nucleosome occupancy or reduced
antibody accessibility caused by a condensed chromatin
structure of the Cd4 locus. However, ChIP experiments
performed with anti-histone H3 or anti-histone H4 gave
similar enrichment over the silencer region in both wild-
type and Mi-2b mutant thymocytes (Figure 5B), ruling
out these possibilities.ImWe next examined the amount of AcH3 over the Cd4 si-
lencer as well as over other Cd4 regulatory regions at
different stages of T cell development (Figures 5C and
5D). At the DN stage of T cell differentiation when the si-
lencer is active, the amount of AcH3 was low over both
the silencer and promoter regions. Nonetheless, a moder-
ate amount of AcH3 was detected over the proximal
enhancer relative to other regulatory regions. The openmunity 27, 723–734, November 2007 ª2007 Elsevier Inc. 729
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Mi-2b Antagonizes Ikaros on Cd4 Silencer ActivityFigure 5. Dynamic Changes in Histone
Acetylation at the Cd4 Silencer during T
Cell Development
(A) Enrichment of the Cd4 silencer with AcH3
and AcH4 in total thymocytes is dependent
on Mi-2b. ChIP that used a-AcH3 or a-AcH4
antibodies was performed with WT (black)
andDMi-2b (gray) thymocytes. Intron 1a is a re-
gion 1 kb upstream from the silencer and
downstream from exon 1, whereas Intron 1b
is1 kb downstream from the silencer. Repre-
sentative data from five (AcH3) or three (AcH4)
independent experiments are shown.
(B) Histone occupancy is not affected by the
Mi-2b depletion. ChIP that used a-histone H3
or a-histone H4 was performed, and the
amount of precipitated DNA was plotted as
a percentage of the input DNA. Representative
results of two independent experiments are
shown.
(C) Developmental changes in histone H3 acet-
ylation over the Cd4 locus. WT cells from the
DN, DP, CD4+ SP, and CD8+ SP stages of T
cell development were purified and subjected
to ChIP with a-AcH3 antibody. The results of
multiplex-PCR for the regulatory and other
genomic regions of the Cd4 locus are shown
(I, input; and A, a-AcH3). White arrowheads
indicate the internal control bands. The results
are representative of two independent studies.
(D) A graphical representation of the develop-
mental changes in AcH3 over the Cd4 locus.
The silencer region is highly acetylated in DP
and CD4+ SP stages, which express CD4, but
not in DN and CD8+ SP stages, which do not.
Note that the scale for the DP panel is greater
than that for the others.chromatin configuration of the Cd4 enhancer correlates
with the fact that the enhancer is turned on at this stage
of development but unable to activate in the context of
the active Cd4 silencer (Sawada and Littman, 1991;730 Immunity 27, 723–734, November 2007 ª2007 Elsevier IncSawada et al., 1994; Siu et al., 1994). At the DP stage,
the silencer becomes inactive, thus allowing CD4 expres-
sion. At this developmental stage, the chromatin over the
silencer, enhancer, and promoter was highly acetylated.
Immunity
Mi-2b Antagonizes Ikaros on Cd4 Silencer Activity(AcH3) compared to other Cd4 intragenic regions (Figures
5C and 5D, exon 2 and 10). Notably, the amount of AcH3
over the silencer exceeds those detected over the proxi-
mal enhancer and promoter regions. In CD4+ SP T cells,
chromatin acetylation (AcH3) was reduced over both the
proximal enhancer and promoter, suggesting that these
epigenetic markings were required for establishing an
active chromatin domain at the DP stage and that subse-
quent maintenance of expression in CD4+ SP T cells was
achieved through other mechanisms. Interestingly, AcH3
over the Cd4 silencer remained at a greater amount com-
pared to the rest of the regulatory regions, indicating that
silencer acetylation might be important for its mainte-
nance in a functionally inactive state (Figures 5C and
5D). Finally, in CD8+ SP T cells, chromatin acetylation
(AcH3) was detected at a low amount over all Cd4 regula-
tory elements including the silencer.
These results demonstrate that the Cd4 silencer un-
dergoes dynamic changes in chromatin structure and his-
tone acetylation during T cell development, and these
changes are in part independent of those occurring in
other Cd4 regulatory regions. They also provide us with
a strong correlation between histone hyperacetylation and
silencer inactivation.
DISCUSSION
Here, we provide first evidence that during T cell develop-
ment, the activity of a negative regulatory domain, that of
the Cd4 silencer, is controlled by the interplay between
positive- and negative-acting chromatin regulators, both
of which can bind to this region concomitantly possibly
as part of a higher-order complex. Loss of a negative or
a positive regulator tips the balance toward activation or
repression ofCd4gene expression at inappropriate stages
of T cell differentiation.
We have previously shown that a major fraction of the
lymphoid lineage-determining DNA-binding factor Ikaros
physically associates with the chromatin remodeler Mi-
2b of the NuRD complex in thymocytes. However, the
functional consequence of this biochemical interaction
remains unknown. Our current genetic studies provide
new insight into a functional, albeit opposing, interaction
between Ikaros and Mi-2b in the regulation of Cd4 gene
expression during T cell development. Expression of
CD4 in DP thymocytes was dependent on Mi-2b because
loss of this chromatin remodeler resulted in loss of the
coreceptor at this stage of T cell differentiation. Although
loss of Ikaros from DP thymocytes did not affect CD4
expression, its combined inactivation with Mi-2b restored
CD4 expression to normal DP levels. In support of Ikaros
as a negative regulator of Cd4 gene expression during T
cell differentiation, lack of Ikaros in DN thymocytes caused
a premature activation of the Cd4 locus.
One prevailing model is that Mi-2b in DP thymocytes
directly antagonizes and counteracts a repressive activity
provided by Ikaros to the Cd4 locus through the Cd4 si-
lencer. It is also possible that the Ikaros-Mi-2b antagonis-
tic interactions are manifested through the Cd4 proximalImenhancer, a regulatory element also dependent on Mi-2b
for its activity (Williams et al., 2004). Also in this case,
loss of Mi-2b might allow an Ikaros-negative activity to
prevail and interfere with enhancer activity and activation
of the Cd4 locus. Further genetic and biochemical studies
with these factors on the Cd4 enhancer are required for
evaluation of this additional possibility. A third possibility
is that Ikaros and Mi-2b function independently of each
other. In this case, the Ikaros mutation restores CD4 ex-
pression in the absence of Mi-2b by activating a positive
regulatory network of factors that function independently
of Mi-2b. Several independent lines of genetic and bio-
chemical evidence on Ikaros and Mi-2b interactions with
the Cd4 silencer presented here provide strong support
for the first model.
The role of Mi-2b in modulating the Cd4 silencer func-
tion was investigated in the context of a Cd4 silencer-
based transgenic reporter. In wild-type DP thymocytes,
an upregulation in the expression of the transgenic re-
porter is normally observed as a result of Cd4 silencer
inactivation. In contrast, inMi-2bmutant cells, reporter ex-
pression never reached normal amounts, indicating per-
sisting silencer activity. Thus, Mi-2b is required for the
effective functional inactivation of the Cd4 silencer during
the DN-to-DP transition. In the absence of Mi-2b, the si-
lencer remained inappropriately active, because of an un-
checked repression activity possibly provided by Ikaros,
thereby causing reduced expression of a silencer-based
reporter or of the Cd4 gene in DP thymocytes.
Because the amount of Mi-2b or Ikaros proteins do not
change during T cell development (Williams et al., 2004) in
a manner that can account for the observed changes in
silencer activity, recruitment of these factors and their as-
sociate activities to the Cd4 silencer might be responsible
for silencer regulation and the observed phenotypes. A
further examination of theCd4 silencer suggested that oc-
cupancy of the region by positive chromatin regulators
upon transition from the DN to the DP stage of T cell devel-
opment is the mechanism of silencer inactivation.
Ikaros, which was identified genetically as a negative
regulator of CD4 expression, was found to be associated
with the Cd4 silencer in DN and DP thymocytes. Ikaros’
ability to participate in Cd4 repression through the Cd4 si-
lencer during DN stage could be accounted by its interac-
tions with resident histone deacetylases and associated
corepressors such as Sin3A (Alland et al., 2002; Unhavai-
thayaet al., 2002). Another possiblemodeof Ikaros repres-
sion through theCd4 silencer might be provided by its sta-
ble association with the SWI-SNF complex in thymocytes
(Kim et al., 1999). The SWI-SNF complex is a potent re-
pressor of CD4 expression in DN thymocytes that like
Ikaros binds to theCd4 silencer in both DN and DP thymo-
cytes (Chi et al., 2002). Thus, an Ikaros-SWI-SNF complex
working in associationwithHDACs is a likelymechanismof
repression at this stage of development.
Whereas Ikaros association with the Cd4 silencer is ev-
ident in DN thymocytes, Mi-2b association is not apparent
until the DP stage. The additional recruitment of an Mi-2b
remodeling complex to this regulatory region appears tomunity 27, 723–734, November 2007 ª2007 Elsevier Inc. 731
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by stably residing chromatin-regulating factors such as
SWI-SNF and HDACs. A key issue is how Mi-2b is re-
cruited to the Cd4 silencer. In the absence of Ikaros,
a small decrease in Mi-2b recruitment was observed.
The presence of Aiolos (Morgan et al., 1997), an Ikaros
family member that has similar DNA-binding properties,
is highly expressed in thymocytes, and is part of the
same higher-order remodeling complexes (Kim et al.,
1999), can rescue for the most part Mi-2b recruitment in
the absence of Ikaros. It is also possible that Mi-2b is re-
cruited to the region through other resident proteins simi-
lar to the Runx.
The ability of Mi-2b to negatively modulate Cd4 silencer
activity does not stem from any effects on the association
of negative regulators such as Ikaros, Runx1, HDAC, or
Sin3 with this region. These appear to be stably associ-
ated with the silencer in CD4-expressing and -nonex-
pressing thymocytes. Instead, the recruitment of HATs,
i.e., MOZ and TAFII250, to the Cd4 silencer is dependent
on Mi-2b. This is consistent with the decrease in histone
acetylation observed over the silencer and the concomi-
tant repression of Cd4 in Mi-2b-deficient DP thymocytes.
Interestingly, MOZ has been reported to also interact with
the Runx family of proteins, which in the case of the Cd4
locus function as negative regulators (Kitabayashi et al.,
2001; Pelletier et al., 2002). Despite their role in repression
and silencing, Runx proteinsmight also serve as a scaffold
for HAT recruitment.
We further investigated the relevance of the Cd4 si-
lencer’s interactions with disparate chromatin regulators
by studying the Cd4 silencer’s chromatin structure. Dy-
namic changes in histone acetylation were observed
over the Cd4 silencer and correlate with changes in its
activity during T cell development. At developmental
stages where the silencer is inactive (i.e., in DP thymo-
cytes), the region is associated with a high degree of his-
tone acetylation. Upon loss of Mi-2b, silencer hyperacety-
lation is greatly reduced, and the silencer becomes
inappropriately activated. Thus, changes in the level of his-
tone acetylation over the Cd4 silencer, as mediated by
Mi-2b or other means, is a likely mechanism by which the
silencer and the transcriptional activity of the Cd4 locus
are modulated during the DN-to-DP transition. Changes
in the amount of histone acetylation were previously ex-
cluded as a means of repressing the Cd4 locus in mature
CD8+ SP cells (Zou et al., 2001). However, the mechanism
by which the silencer achieves CD4 repression in DN
thymocytes appears to be distinct. Different factors are re-
sponsible forCd4 silencing in the early DN thymocyte pre-
cursors (i.e., Ikaros andRunx1) versus thematureCD8+SP
(i.e., Runx3) cells (Taniuchi et al., 2002a). Upon productive
rearrangement of the Tcrb locus, DN thymocytes must
rapidly acquire CD4 expression, indicating that the repres-
singmechanism adopted by these cells must be turned off
rapidly. This can be readily achieved by altering the his-
tone-acetylation amounts over theCd4 silencer. However,
when a thymocyte commits to the CD8+ lineage, the Cd4
locus becomes permanently silenced. Once this is estab-732 Immunity 27, 723–734, November 2007 ª2007 Elsevier Inlished, a distinct epigenetic mechanism is involved in
maintaining CD4 silencing even upon removal of the Cd4
silencer (Zou et al., 2001).
Taking together past and current genetic and biochem-
ical studies on functionally opposing chromatin regulators
working through the Cd4 silencer, we are now providing
a new model for Cd4 gene regulation during T cell devel-
opment. According to this model, the zinc-finger DNA-
binding factor Ikaros and its family members (i.e., Aiolos
and Helios [Hahm et al., 1998; Kelley et al., 1998]) serve
as key intermediaries in this regulatory system by promot-
ing the recruitment of both negative and positive factors
that varies depending on the developmental stage. At
the DN stage, recruitment of only negative regulators
(i.e., SWI-SNF and HDACs) leads to CD4 repression.
At the DP stage, Ikaros allows the additional recruitment
of positive chromatin regulators (i.e., Mi-2b and HATs)
whose activity overrides that of resident negative regula-
tors (i.e., SWI-SNF and HDACs). This promotes silencer
inactivation and induces CD4 expression. Aberrant loss
of Ikaros in DN cells or loss of Mi-2b in DP cells alters
the balance between these opposing chromatin activities
manifested upon the silencer, leading to the respective
derepression or repression of theCd4 locus at inappropri-
ate stages of T cell development.
These studies on Ikaros and Mi-2b interactions with
respect to Cd4 silencer regulation provide us with a new
paradigm by which the potential for expression of line-
age-specific genes is established and modulated during
development. A further genome-wide analysis of the
associations of these pioneering transcription and chro-
matin regulators and their effects on chromatin structure
will provide us with a global picture on how lineage-
specific chromatin states are set up or modulated during
development.
EXPERIMENTAL PROCEDURES
Mice
We achieved T cell-specific deletion of Mi-2b by crossing Chd4Lox/Lox
to Lckpr-Cre as previously described (Williams et al., 2004). The Ikaros
null mutant was described by (Wang et al., 1996). The Cd4 silencer
transgenic reporter was kindly provided by Dr. Dan Littman. A control
transgenic reporter lacking the silencer was generated from the paren-
tal construct. All animal experimentation protocols were approved by
the Massachusetts General Hospital Subcommittee on Research
Animal Care (Charlestown, Massachusetts).
Flowcytometry Analyses
We used the following antibodies to profile thymocyte subsets on a
wild-type or each mutant background: PE-Cy5.5-CD4 (Caltag), FITC-
CD8a, FITC-TCRb, FITC-TCRgd, FITC-B220, FITC-Ter119, FITC-
Mac-1, FITC-Gr-1, PE-CD5, PE-hCD2, APC-TCRb, APC-CD44, and
APC-Cy7-CD25 (BD Bioscience). FACS data were collected with
FACSCanto or FACSCalibur (BD Bioscience) and analyzed with the
FlowJo software (Tree Star).
Chromatin-Immunoprecipitation Studies
Chromatin immunoprecipitation (ChIP) was performed as described
previously (Harker et al., 2002) with total thymocytes of wild-type
and Mi-2b mutant unless noted otherwise. DN cells were obtained
from the Rag1 knockout thymus, DP cells were obtained from thec.
Immunity
Mi-2b Antagonizes Ikaros on Cd4 Silencer ActivityTCRa knockout thymus, and CD4+ and CD8+ SP cells were purified
from spleen with immunodepletion columns (Cederlane). In the case
of HDAC2 and Sin3A detection, cells were fixed with DTBP prior to
formaldehyde crosslinking (Fujita et al., 2003). Antibodies used for
ChIP were a-Mi-2b (Kim et al., 1999), a-H3, a-H4 a-AcH3, and a-
AcH4 (UpState Biotech), a-HDAC2 (Zymed), a-Sin3A, a-MOZ, and
a-TAFII250 (SantaCruz), and a-AML1/Runx1 (Oncogene Research).
Precipitated DNA was subjected to analysis either by duplex PCR or
real-time PCR. The 31st intronic region of Brg1 gene was used as
an internal control for the duplex PCR reactions (Chi et al., 2002).
The sequences of primers used for PCR analyses are available upon
request.
Supplemental Data
Three figures are available at http://www.immunity.com/cgi/content/
full/27/5/723/DC1/.
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